NCT06995040View on ClinicalTrials.gov

BREMISS : Brain Resilience Minor Stroke Study

NANot yet recruitingINTERVENTIONAL
Enrollment

1,000

Participants

Timeline

Start Date

June 1, 2025

Primary Completion Date

December 1, 2027

Study Completion Date

December 1, 2028

Conditions
Stroke Ischemic
Interventions
DIAGNOSTIC_TEST

Cerebral MRI without contrast agent injection

Cerebral MRI at inclusion or after

GENETIC

saliva sample

Saliva sample for DNA analysis at inclusion or send to their home.

OTHER

Questionnaires

Quality of life and cognitive questionnaires at inclusion

Trial Locations (1)

29609

CHU de Brest, Brest

All Listed Sponsors
lead

University Hospital, Brest

OTHER

NCT06995040 - BREMISS : Brain Resilience Minor Stroke Study | Biotech Hunter | Biotech Hunter